DigiPath Labs Signs Cannabis Testing Agreement with Waveseer of Las Vegas

1

​LAS VEGAS, NV, January 26, 2015 – DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), has just signed a one-year agreement with another Nevada medicinal cannabis grower, Waveseer of Las Vegas. DigiPath Labs will use its state-of-the-art testing equipment and reliable testing methodologies to determine safety and potency profiles of Waveseer’s cannabis material.

“We are excited to perform cannabis testing for Waveseer, they’re dedicated to ensuring every plant meets the strict standards of the State of Nevada, and we anticipate a long, productive partnership.”

“We were immediately impressed with the customer service, professionalism, testing protocol, and mission of DigiPath Labs,” says Gareth Nelson, Operations Director at Waveseer of Las Vegas. “Providing safe, clean medicine to Nevada patients is our mission, and this partnership will help us in gaining patient trust and loyalty.”

DigiPath Labs’ state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and then created and verified standard operating procedures to ensure reliable, replicable results.

Waveseer of Las Vegas is a licensed medical cannabis grower located in North Las Vegas that has been fully licensed and growing for a few months.

DigiPath Labs will test all cannabis products grown and produced by Waveseer for potency, terpenoids, moisture content, foreign matter, heavy metals, microbials, mycotoxins, and pesticide residue.

“Nevada’s cannabis industry is just getting started, but it’s already leading the country in terms of careful oversight and concern for patient safety,” says Denkin. “Waveseer of Las Vegas is set up for success in this environment, and we look forward to helping them help patients.”

“Nevada’s cannabis industry is just getting started, but it’s already leading the country in terms of careful oversight and concern for patient safety,” says Denkin. “Waveseer of Las Vegas is set up for success in this environment, and we look forward to helping them help patients.”

Contact:

DigiPath, Inc.

Investor Relations

702.470.2249

[email protected]

Share.